|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aoki Y, Kanao H, Wang X, Yunokawa M,
Omatsu K, Fusegi A and Takeshima N: Adjuvant treatment of
endometrial cancer today. Jpn J Clin Oncol. 50:753–765. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Slavoff SA, Mitchell AJ, Schwaid AG,
Cabili MN, Ma J, Levin JZ, Karger AD, Budnik BA, Rinn JL and
Saghatelian A: Peptidomic discovery of short open reading
frame-encoded peptides in human cells. Nat Chem Biol. 9:59–64.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seitz AK, Christensen LL, Christensen E,
Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM,
Palmfeldt J, Thomson M, et al: Profiling of long non-coding RNAs
identifies LINC00958 and LINC01296 as candidate oncogenes in
bladder cancer. Sci Rep. 7:3952017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He W, Zhong G, Jiang N, Wang B, Fan X,
Chen C, Chen X, Huang J and Lin T: Long noncoding RNA BLACAT2
promotes bladder cancer-associated lymphangiogenesis and lymphatic
metastasis. J Clin Invest. 128:861–875. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zuo X, Chen Z, Gao W, Zhang Y, Wang J,
Wang J, Cao M, Cai J, Wu J and Wang X: M6A-mediated upregulation of
LINC00958 increases lipogenesis and acts as a nanotherapeutic
target in hepatocellular carcinoma. J Hematol Oncol. 13:52020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao H, Zheng GH, Li GC, Xin L, Wang YS,
Chen Y and Zheng XM: Long noncoding RNA LINC00958 regulates cell
sensitivity to radiotherapy through RRM2 by binding to
microRNA-5095 in cervical cancer. J Cell Physiol. 234:23349–23359.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Xu Z, Zhang Y and Zhang X:
LINC00958 promotes the malignancy of nasopharyngeal carcinoma by
sponging microRNA-625 and thus upregulating NUAK1. Onco Targets
Ther. 12:9277–9290. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen S, Chen JZ, Zhang JQ, Chen HX, Qiu
FN, Yan ML, Tian YF, Peng CH, Shen BY, Chen YL and Wang YD:
Silencing of long noncoding RNA LINC00958 prevents tumor initiation
of pancreatic cancer by acting as a sponge of microRNA-330-5p to
down-regulate PAX8. Cancer Lett. 446:49–61. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Z, Han Z, Shou F, Li Y and Chen Y:
LINC00958 accelerates cell proliferation and migration in non-small
cell lung cancer through JNK/c-JUN signaling. Hum Gene Ther
Methods. 30:226–234. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu H, Kong Q, Huang XX, Zhang HR, Hu KF,
Jing Y, Jiang YF, Peng Y, Wu LC, Fu QS, et al: Longnon-coding RNA
BLACAT2 promotes gastric cancer progression via the
miR-193b-5p/METTL3 pathway. J Cancer. 12:3209–3221. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren Y, Zhao C, He Y, Xu H and Min X: Long
non-coding RNA bladder cancer-associated transcript 2 contributes
to disease progression, chemoresistance and poor survival of
patients with colorectal cancer. Oncol Lett. 18:2050–2058.
2019.PubMed/NCBI
|
|
18
|
Zhu J, Zhu Z, Cai P, Gu Z and Wang J:
Bladder cancer-associated transcript 2 contributes to
nephroblastoma progression. J Gene Med. 24:e32922022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Binang HB, Wang YS, Tewara MA, Du L, Shi
S, Li N, Nsenga AGA and Wang C: Expression levels and associations
of five long non-coding RNAs in gastric cancer and their clinical
significance. Oncol Lett. 19:2431–2445. 2020.PubMed/NCBI
|
|
20
|
Chen BJ, Byrne FL, Takenaka K, Modesitt
SC, Olzomer EM, Mills JD, Farrell R, Hoehn KL and Janitz M:
Transcriptome landscape of long intergenic non-coding RNAs in
endometrial cancer. Gynecol Oncol. 147:654–662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang Y, Qiao Z, Jiang J and Zhang J:
LINC00958 promotes endometrial cancer cell proliferation and
metastasis by regulating the miR-145-3p/TCF4 axis. J Gene Med.
23:e33452021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khachigian LM: The Yin and Yang of YY1 in
tumor growth and suppression. Int J Cancer. 143:460–465. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sarvagalla S, Kolapalli SP and
Vallabhapurapu S: The two sides of YY1 in cancer: A friend and a
foe. Front Oncol. 9:12302019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas MJ and Seto E: Unlocking the
mechanisms of transcription factor YY1: Are chromatin modifying
enzymes the key? Gene. 236:197–208. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang
X, Xu S and Pang D: LINC00673 is activated by YY1 and promotes the
proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo
signaling pathway. J Exp Clin Cancer Res. 38:4182019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Berchuck A, Iversen ES, Lancaster JM,
Pittman J, Luo J, Lee P, Murphy S, Dressman HK, Febbo PG, West M,
et al: Patterns of gene expression that characterize long-term
survival in advanced stage serous ovarian cancers. Clin Cancer Res.
11:3686–3696. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seligson D, Horvath S, Huerta-Yepez S,
Hanna S, Garban H, Roberts A, Shi T, Liu X, Chia D, Goodglick L and
Bonavida B: Expression of transcription factor Yin Yang 1 in
prostate cancer. Int J Oncol. 27:131–141. 2005.PubMed/NCBI
|
|
28
|
Luo J, Zhou X, Ge X, Liu P, Cao J, Lu X,
Ling Y and Zhang S: Upregulation of Ying Yang 1 (YY1) suppresses
esophageal squamous cell carcinoma development through heme
oxygenase-1. Cancer Sci. 104:1544–1551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao G, Li Q, Wang A and Jiao J: YY1
regulates melanoma tumorigenesis through a miR-9~RYBP axis. J Exp
Clin Cancer Res. 34:662015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang
P, Chan LK, Zhang T, Yu J, Kwong J, et al: A novel
miR-193a-5p-YY1-APC regulatory axis in human endometrioid
endometrial adenocarcinoma. Oncogene. 32:3432–3442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Masood N, Basharat Z, Khan T and Yasmin A:
Entangling relation of micro RNA-let7, miRNA-200 and miRNA-125 with
various cancers. Pathol Oncol Res. 23:707–715. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao M, Iglinski-Benjamin KC, Sharpe O,
Robinson WH and Abrams GD: Exogenous micro-RNA and antagomir
modulate osteogenic gene expression in tenocytes. Exp Cell Res.
378:119–123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang T, Sui D, You D, Yao S, Zhang L,
Wang Y, Zhao J and Zhang Y: MiR-29a-5p inhibits proliferation and
invasion and induces apoptosis in endometrial carcinoma via
targeting TPX2. Cell Cycle. 17:1268–1278. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang P, Zeng Z, Shen X, Tian X and Ye Q:
Identification of a multi-RNA-type-based signature for
recurrence-free survival prediction in patients with uterine corpus
endometrial carcinoma. DNA Cell Biol. 39:615–630. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cui Y, Xie M and Zhang Z: LINC00958
involves in bladder cancer through sponging miR-378a-3p to elevate
IGF1R. Cancer Biother Radiopharm. 35:776–788. 2020.PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thomas GJ, Lewis MP, Hart IR, Marshall JF
and Speight PM: AlphaVbeta6 integrin promotes invasion of squamous
carcinoma cells through up-regulation of matrix
metalloproteinase-9. Int J Cancer. 92:641–650. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang L, Zhong Y, Yang B, Zhu Y, Zhu X, Xia
Z, Xu J and Xu L: LINC00958 facilitates cervical cancer cell
proliferation and metastasis by sponging miR-625-5p to upregulate
LRRC8E expression. J Cell Biochem. 121:2500–2509. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xie M, Fu Q, Wang PP and Cui YL:
STAT1-induced upregulation lncRNA LINC00958 accelerates the
epithelial ovarian cancer tumorigenesis by regulating Wnt/β-catenin
signaling. Dis Markers. 2021:14050452021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang D, Ma Q, Wang Z, Zhang M, Guo K,
Wang F and Wu E: β2-adrenoceptor blockage induces G1/S phase arrest
and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway.
Mol Cancer. 10:1462011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sato H, Takino T, Okada Y, Cao J,
Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase
expressed on the surface of invasive tumour cells. Nature.
370:61–65. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ouyang D, Li R, Li Y and Zhu X: A 7-lncRNA
signature predict prognosis of uterine corpus endometrial
carcinoma. J Cell Biochem. 120:18465–18477. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S,
Zhang M, Yu F, Peng Z and Zhou C: Elevated HOXA1 expression
correlates with accelerated tumor cell proliferation and poor
prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer
Res. 35:152016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Park GH, Song HM and Jeong JB: The coffee
diterpene kahweol suppresses the cell proliferation by inducing
cyclin D1 proteasomal degradation via ERK1/2, JNK and
GKS3β-dependent threonine-286 phosphorylation in human colorectal
cancer cells. Food Chem Toxicol. 95:142–148. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu H, Zeng Z, Wang S, Li T, Mastriani E,
Li QH, Bao HX, Zhou YJ, Wang X, Liu Y, et al: Main components of
pomegranate, ellagic acid and luteolin, inhibit metastasis of
ovarian cancer by down-regulating MMP2 and MMP9. Cancer Biol Ther.
18:990–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang Y, Zhu Y, Zhang L, Tian W, Hua S,
Zhao J, Zhang H and Xue F: Insulin promotes proliferation,
survival, and invasion in endometrial carcinoma by activating the
MEK/ERK pathway. Cancer Lett. 322:223–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang F, Chen Q, Huang G, Guo X, Li N, Li Y
and Li B: BKCa participates in E2 inducing endometrial
adenocarcinoma by activating MEK/ERK pathway. BMC Cancer.
18:11282018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhao Z, Sun W, Guo Z, Zhang J, Yu H and
Liu B: Mechanisms of lncRNA/microRNA interactions in angiogenesis.
Life Sci. 254:1169002020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liu C, Zhang YH, Deng Q, Li Y, Huang T,
Zhou S and Cai YD: Cancer-related triplets of mRNA-lncRNA-miRNA
revealed by integrative network in uterine corpus endometrial
carcinoma. Biomed Res Int. 2017:38595822017.PubMed/NCBI
|
|
55
|
Kong D, Hou Y, Li W, Ma X and Jiang J:
LncRNA-ZXF1 regulates P21 expression in endometrioid endometrial
carcinoma by managing ubiquitination-mediated degradation and
miR-378a-3p/PCDHA3 axis. Mol Oncol. 16:813–829. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rong D, Dong Q, Qu H, Deng X, Gao F, Li Q
and Sun P: m6A-induced LINC00958 promotes breast cancer
tumorigenesis via the miR-378a-3p/YY1 axis. Cell Death Discov.
7:272021. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Painter JN, Kaufmann S, O'Mara TA, Hillman
KM, Sivakumaran H, Darabi H, Cheng THT, Pearson J, Kazakoff S,
Waddell N, et al: A common variant at the 14q32 endometrial cancer
risk locus activates AKT1 through YY1 binding. Am J Hum Genet.
98:1159–1169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bhaskar Rao D, Panneerpandian P,
Balakrishnan K and Ganesan K: YY1 regulated transcription-based
stratification of gastric tumors and identification of potential
therapeutic candidates. J Cell Commun Signal. 15:251–267. 2021.
View Article : Google Scholar : PubMed/NCBI
|
